Till umu.se

Anders Widmark

Professor/överläkare vid Institutionen för strålningsvetenskaper
Ställföreträdande prefekt
Onkologi

Publikationer

Författare

Titel

År sorteringsordning

Fulltext

Sooriakumaran, Prasanna
Nyberg, Tommy
Akre, Olof; et al.

Survival Among Men at High Risk of Disseminated Prostate Cancer Receiving Initial Locally Directed Radical Treatment or Initial Androgen Deprivation Therapy
European Urology, 72(3): 345-351

2017

-

Bosco, Cecilia
Garmo, Hans
Adolfsson, Jan; et al.

Prostate Cancer Radiation Therapy and Risk of Thromboembolic Events
International Journal of Radiation Oncology, Biology, Physics, 97(5): 1026-1031

2017

Hämta

Vogelzang, Nicholas J.
Coleman, Robert E.
Michalski, Jeff M.; et al.

Hematologic Safety of Radium-223 Dichloride: Baseline Prognostic Factors Associated With Myelosuppression in the ALSYMPCA Trial
Clinical Genitourinary Cancer, 15(1): 42-52

2017

Hämta

Nordstrand, Annika
Halin Bergström, Sofia
Thysell, Elin; et al.

Inhibition of the insulin-like growth factor-1 receptor potentiates acute effects of castration in a rat model for prostate cancer growth in bone
Clinical and Experimental Metastasis, 34(3-4): 261-271

2017

Hämta

Andren, O.
Widmark, Anders
Falt, A.; et al.

Cabazitaxel followed by androgen deprivation therapy (ADT) significantly improves time to progression in patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A randomized, open label, phase III, multicenter trial
Annals of Oncology, 28

2017

-

Bovinder Ylitalo, Erik
Thysell, Elin
Jernberg, Emma; et al.

Subgroups of castration-resistant prostate cancer bone metastases defined through an inverse relationship between androgen receptor activity and immune response
European Urology, 71(5): 776-787

2017

Hämta

Wänman, Johan
Grabowski, Pawel
Nyström, Helena; et al.

Metastatic spinal cord compression as the first sign of malignancy: Outcome after surgery in 69 patients
Acta Orthopaedica, 88(4): 457-462

2017

-

Djusberg, Erik
Jernberg, Emma
Thysell, Elin; et al.

High Levels of the AR-V7 Splice Variant and Co-Amplification of the Golgi Protein Coding YIPF6 in AR Amplified Prostate Cancer Bone Metastases
The Prostate, 77(6): 625-638

2017

-

Bossi, A.
Dearnaley, D.
McKenzie, M.; et al.

ATLAS: A phase 3 trial evaluating the efficacy of apalutamide (ARN-509) in patients with high-risk localized or locally advanced prostate cancer receiving primary radiation therapy
Annals of Oncology, 27

2016

-

Widmark, Anders
Gunnlaugsson, A.
Beckman, L.; et al.

Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial "HYPO-RT-PC"
International Journal of Radiation Oncology, Biology, Physics, 96(5): 938-939

2016

-


Sidansvarig: Maria Wing

Utskriftsversion